Let me know when the data is updated again

CANAPHARMA SA DE CV

Summary of sales of medicines and medical supplies

1,217 purchase as supplier for a total of 48.5 millones (48,497,195.793 ) between 2009 and 2019.

Annual evolution of purchase
Procedure type
Top buyers



Largest purchase



Total overcost

Overcost in MXN

12 millones pesos mexicanos (12,015,819.277 MXN)

Overcost in %

90 %

Top products
Product Purchases Total amount Overcost in MXN Overcost in % Period
FLUDROCORTISONA 57 1 millones MXN 1,071 MXN 0.892 % 2013 - 2017
CICLOSPORINA 40 454,113.2 MXN 179,679.7 MXN 463.1 % 2015 - 2017
DIFENHIDRAMINA 25 325,921.5 MXN 16,296.8 MXN 10 % 2014 - 2016
DIGOXINA 22 2.2 millones MXN 460.2 MXN 0.978 % 2015 - 2016
CICLOSPORINA 20 452,552 MXN 114,797 MXN 233 % 2015 - 2017
ÁCIDO AMINOCAPROICO 18 1.1 millones MXN 189,667 MXN 40.3 % 2013 - 2018
L-ASPARAGINASA 16 651,832 MXN 41,060.2 MXN 15.1 % 2015 - 2018
VALGANCICLOVIR 16 816,397.5 MXN 25,318.2 MXN 26.4 % 2011 - 2016
GOSERELINA 15 185,012.8 MXN 48,380.6 MXN 54.1 % 2012 - 2016
TOXINA BOTULÍNICA TIPO A 15 302,519.7 MXN 72,683.7 MXN 34.6 % 2015 - 2016

Location

Country

México

GENERAL INFORMATION

Alternative names

  • CANAPHARMA S.A. DE C.V.
  • CANAPHARMA, S.A. DE C.V.
  • CANAPHARMA, SA DE CV
  • CANAPHARMA S.A DE C.V
  • CANAPHARMA S.A DE C.V.

Entity type

profit

Identifiers

RUPC: 118767

RFC: CAN080701DN6

Date updated in QQW

24 de enero de 2019

Organization responsible for the import

PODER